Catalyst Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $496.35 million, with shareholders equity totaling $183.85 million.
The company employs approximately 56 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Catalyst Biosciences Inc. reported $11.88 million in revenue, generating net income of $-162.08 million.
Key financial metrics include a P/E ratio of -3.06, a price-to-book (P/B) ratio of 2.70, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CBIO.